Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.03.09.633849

Cellular characterization of the peritumoral brain zone of glioblastomas: heterogenous nature and clinical relevance.

Abstract

BackgroundGlioblastoma (GBM) is a highly aggressive cancer with near-universal recurrence, often due to residual tumor cells that persist after aggressive standard of care treatment. This study aimed to characterize tumor infiltration and microenvironment in the GBM periphery. MethodsWe prospectively collected 161 radiologically guided biopsies from 45 GBM patients and conducted an immunohistochemical analysis. We also integrated single-cell RNA sequencing data to select specific markers for immune, glial, and vascular cells. We measured the expression of these genes in samples from contrast-enhancing (CE) and non-enhancing (nCE) tumor areas, vasogenic edema, and radiologically normal tissue. Correlations with resection extent and clinical outcomes were evaluated. ResultsnCE biopsies exhibited neoplastic features similar to those of the tumor core. However, tumor infiltration was also found in regions classified radiologically as edema, particularly in elderly patients. We found important differences in the composition of the peripheral microenvironment between male and female GBM patients. Prognostic associations with specific cell types, such as myeloid cells, showed intertumor heterogeneity, with variations depending on patient sex, age and extent of resection. Furthermore, in our cohort, minimal residual CE tumor following surgery was associated with significantly poorer patient survival. ConclusionsThe GBM periphery includes regions of active tumor growth that are visible on MRI, as well as infiltrated areas that resemble edema radiologically. Tumor infiltration and microenvironmental features are influenced by patient sex and age, which has major implications for recurrence rates, highlighting the need to tailor surgical and therapeutic strategies based on tumor biology and patient subgroup. Key pointsnCE areas show similar neoplastic traits to the CE tumor. GBM infiltrates edema tissue, predominantly in older adult patients. Prognostic value of the peritumoral phenotype depends on resection extent and patient age/sex. Importance of the studyThis study shows that the impact of peripheral and core cellular features on prognosis differs between patients who undergo complete versus incomplete CE tumor resection. Our results suggest a paradigm shift in the classification and management of these patients, encouraging the inclusion of detailed post-surgical MRI analyses to guide the design of future clinical trials according to the nature and extent of the residual disease. Furthermore, our data confirm the presence of tumorigenic features in non-enhancing areas, supporting the benefits of supratotal resections according to the new RANO classification. Our findings also underscore the need to refine surgical and therapeutic strategies based on a more detailed understanding of the tumor microenvironment beyond the GBM core. This understanding may help identify novel targets for more effective and personalized GBM therapies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

deDios, O., Romero, J., Ramirez-Gonzalez, M., Herranz-Sanchez, B., Avis, A., Ramos, A., Sepulveda-Sanchez, J. M., Gargini, R., Melendez, B., Gonzalez, P., Jimenez-Roldan, L., Garcia-Posadas, G., Hernandez-Lain, A., Perez-Nunez, A., Sanchez-Gomez, P.. 2025-03-13. Cellular characterization of the peritumoral brain zone of glioblastomas: heterogenous nature and clinical relevance.. https://doi.org/10.1101/2025.03.09.633849

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

m6A-Driven Intratumoral Cholesterol Biosynthesis Fuels Castration-Resistant Prostate Cancer Progression

Both nuclear pore complexes (NPCs) and RNA N6-methyladenosine (m6A) machinery are indispensable for proper cellular function. Although their collaborative roles in the nuclear export of messenger RNAs (mRNAs) have been reported, it remains ambiguous whether and how this collaboration may contribute to cancer progression. Here we identify a functional cooperation between NPCs and m6A signaling that promotes the development of castration-resistant prostate cancer (CRPC). We showed that nuclear export of m6A-modified mRNAs, mediated by the interaction between RNA methyltransferase METTL3 and the nucleoporin NUP93, is functionally coupled to cholesterol biosynthesis. Given that cholesterol-fueled intratumoral androgen production is one of the mechanisms driving CRPC, we demonstrated that overexpression of the wild-type METTL3 or NUP93, but neither the enzymatically dead METTL3 nor the mutant NUP93 that loses METTL3-interacting capability, elevates intracellular levels of androgens, activates AR signaling under castrate condition, and promotes androgen-independent growth of prostate cancer cells both in vitro and in vivo. Importantly, pharmacological inhibition of METTL3 or targeted demethylation on mRNAs encoding key cholesterol biosynthesis enzymes effectively suppressed CRPC malignancy. Together, these findings uncover a therapeutically targetable m6A-METTL3-NUP93 axis that links nuclear mRNA export and metabolic reprogramming to fuel CRPC progression, providing a conceptually new strategy for the treatment of this lethal disease.

cancer biology↗

ST6Gal2 promotes α2,6-sialylation and aggressive phenotypes in neuroblastoma cells

Neuroblastoma is the most common extracranial solid tumor of childhood. Its clinical behavior ranges from spontaneous regression to lethal, treatment-refractory disease. Aberrant 2,6-sialylation contributes to aggressive phenotypes in many cancers, but the role of ST6Gal2, a neural-enriched 2,6-sialyltransferase, in neuroblastoma is largely unexplored. Here, we examine the clinical and functional significance of ST6Gal2 in neuroblastoma. In two independent public cohorts (SEQC, n=498; Kocak, n=649), high ST6GAL2 expression was associated with significantly worse overall and event-free survival. In the SEQC cohort, ST6GAL2 expression was higher in high-risk and MYCN-amplified tumors, varied across International Neuroblastoma Staging System stages, and correlated positively with a mesenchymal transcriptional signature (Spearman {rho}=0.181). The mesenchymal correlation was reproduced in the Kocak cohort ({rho}=0.204). Stable shRNA-mediated knockdown of ST6GAL2 in SK-N-AS and SK-N-BE(2) cells reduced proliferation and viability, impaired wound closure, and decreased migration and invasion. In preliminary experiments in SK-N-AS cells, ST6GAL2 knockdown reduced binding of Sambucus nigra agglutinin, consistent with a role for ST6Gal2 in 2,6-sialylation. Together, these findings link ST6Gal2 expression to aggressive clinical and transcriptional features and pro-tumorigenic phenotypes in neuroblastoma and nominate ST6Gal2-mediated sialylation as a candidate pathway for mechanistic study.

cancer biology↗

Unsupervised transcriptomic analysis of paired pre- and post-treatment specimens reveals divergent chemoimmunomodulatory induction trajectories in breast cancer

The immunomodulatory effects of chemotherapy (chemoimmunomodulation; CIM) are clinically consequential and heterogeneous, yet no systematic framework exists for classifying the immunomodulatory trajectory a tumor follows in response to treatment (CIM trajectory). Here, we present the CIM Induction Classifier (CIMIC), an unsupervised clustering pipeline leveraging delta gene expression across 3,189 CIM-related genes to classify specimens chemoimmunomodulatory trajectory. Applied to two pre- and post-chemotherapy breast cancer (BC) datasets (NKI/SMC, N = 36; NEO, N = 19) and nine epirubicin-perturbed triple-negative BC (TNBC) cell lines, CIMIC identified two divergent CIM trajectories: a functional CIM (Fun-CIM) trajectory, broadly conserved across tumors and cell lines and characterized by induction of inflammatory cell death, antigen presentation, viral mimicry, and adaptive immune activation programs, and a dysfunctional CIM (Dys-CIM) trajectory, characterized by induction of proteostatic and metabolic stress-adaptation programs, reduced immune cell abundances and cytotoxic activity, and enrichment of aggressive BC subtypes. Using survival and longitudinal transcriptomic data in NKI/SMC (N = 20), treatment-induced increases in Fun-CIM-associated genes and ssGSEA scores were associated with reduced recurrence, whereas Dys-CIM-associated genes and scores were associated with increased recurrence. In multivariable analyses within independent chemotherapy-treated BC cohorts (METABRIC, N = 412; SCAN-B, N = 2,462), higher baseline Fun-CIM ssGSEA scores were associated with better outcomes, whereas higher baseline Dys-CIM ssGSEA scores were associated with worse outcomes. These findings establish CIM as a dynamic, trajectory-level process and position CIMIC as a framework for defining CIM trajectories and supporting future efforts to identify predictors, mechanisms, and therapeutic strategies that maximize beneficial CIM.

cancer biology↗